Pfizer Delves Deeper In Generics Partnership With Strides Arcolab
This article was originally published in The Pink Sheet Daily
Pfizer's supply agreement with India-based Strides Arcolab now covers 45 products with a more expansive global marketing reach.
You may also be interested in...
MUMBAI - After partnering with Aurobindo Pharma and Claris to source more than 100 oral and injectable generic drugs last year, Pfizer continues its shopping spree in India as it sealed yet another sourcing deal, this time with Bangalore-based Strides Arcolab
AHMEDABAD, India - Two months after Pfizer signed a comprehensive in-licensing agreement for more than 50 oral and injectable products with Aurobindo Pharma, the U.S. company has entered into another deal, with India's Claris Lifesciences, to commercialize 15 products covering a broad range of therapeutic areas including anti-infectives and pain drugs
Only weeks after announcing its Wyeth acquisition, Pfizer is stepping up its profile in the generics world, looking for branded and commodity opportunities.